Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7865]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
Olapirib in combination with abiraterone delayed disease progression in first line mCRPC
Olapirib in combination with abiraterone delayed disease progression in first line mCRPC
Breast cancers: ruptures in cell nuclei promotes tumour invasion
Breast cancers: ruptures in cell nuclei promotes tumour invasion
Are too many Phase III cancer clinical trials set up to fail?
Are too many Phase III cancer clinical trials set up to fail?
Therapy using dual immune system cells effectively controls neuroblastoma
Therapy using dual immune system cells effectively controls neuroblastoma
Right program could turn immune cells into cancer killers
Right program could turn immune cells into cancer killers
Access to essential cancer medicines unequal across countries
Access to essential cancer medicines unequal across countries
VHIO at ESMO 2021: Reporting advances in breast cancer treatment
VHIO at ESMO 2021: Reporting advances in breast cancer treatment
New method used to study how cancer cells are organised
New method used to study how cancer cells are organised
ESMO 2021: New drug shows promise in slowing growth of bowel cancer
ESMO 2021: New drug shows promise in slowing growth of bowel cancer
ESMO 2021: Immune checkpoint inhibitor atezolizumab as a potential game-changer in the treatment of early-stage NSCLC
ESMO 2021: Immune checkpoint inhibitor atezolizumab as a potential game-changer in the treatment of early-stage...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation